Witnessing the stock’s movement on the chart, on Thursday, Organogenesis Holdings Inc (NASDAQ: ORGO) set off with pace as it heaved 2.51% to $2.86, before settling in for the price of $2.79 at the close. Taking a more long-term approach, ORGO posted a 52-week range of $1.79-$4.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 19.04% for the last half of the decade. Nevertheless, stock’s Earnings Per Share (EPS) this year is -93.21%. This publicly-traded company’s shares outstanding now amounts to $131.32 million, simultaneously with a float of $77.29 million. The organization now has a market capitalization sitting at $377.41 million. At the time of writing, stock’s 50-day Moving Average stood at $3.07, while the 200-day Moving Average is $3.10.
Organogenesis Holdings Inc (ORGO) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Drug Manufacturers – Specialty & Generic industry. Organogenesis Holdings Inc’s current insider ownership accounts for 41.43%, in contrast to 44.54% institutional ownership. According to the most recent insider trade that took place on Jan 10 ’24, this organization’s 10% Owner sold 17,972 shares at the rate of 4.28, making the entire transaction reach 76,875 in total value, affecting insider ownership by 59,007,134. Preceding that transaction, on Jan 10 ’24, Company’s 10% Owner sold 17,972 for 4.28, making the whole transaction’s value amount to 76,875. This particular insider is now the holder of 59,007,134 in total.
Organogenesis Holdings Inc (ORGO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 29.94 per share during the current fiscal year.
Organogenesis Holdings Inc’s EPS decrease for this current 12-month fiscal period is -93.21% and is forecasted to reach 0.08 in the upcoming year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Let’s observe the current performance indicators for Organogenesis Holdings Inc (ORGO). It’s Quick Ratio in the last reported quarter now stands at 2.44. The Stock has managed to achieve an average true range (ATR) of 0.18. Alongside those numbers, its PE Ratio stands at $77.93, and its Beta score is 1.55. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.87. Similarly, its price to free cash flow for trailing twelve months is now 57.62.
In the same vein, ORGO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.04, a figure that is expected to reach -0.02 in the next quarter, and analysts are predicting that it will be 0.08 at the market close of one year from today.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Going through the that latest performance of [Organogenesis Holdings Inc, ORGO]. Its last 5-days volume of 0.73 million was inferior to the volume of 0.76 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 30.85% While, its Average True Range was 0.17.
Raw Stochastic average of Organogenesis Holdings Inc (ORGO) in the period of the previous 100 days is set at 15.95%, which indicates a major fall in contrast to 60.95% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 56.74% that was lower than 74.13% volatility it exhibited in the past 100-days period.
